Lantern Pharma

/Lantern Pharma

IPO

Lantern Pharma

Biotechnology

We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies.

Symbol

LTRN

Price Range
$15.00 - $17.00

Final Shares
1,563,000

Anticipated Date
June 11, 2020

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Lantern Pharma IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277